A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors

Clinical trial NCT07623369 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07623369
Sponsor: Huahui Health
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Non-small Cell Lung Cancer Hepatocellular Carcinoma Colorectal Cancer Head and Neck Squamous Cell Carcinoma Renal Cell Carcinoma Endometrial Cancer Cervical Cancer Small-cell Lung Cancer Triple Negative Breast Cancer Urothelial Carcinoma Gastroesophageal Adenocarcinoma

Start date: 2026-06-01
Primary completion: 2028-08-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.